Results 141 to 150 of about 28,268 (242)

Clinical benefit of faecal microbiota transplantation administered via a single retention enema as an adjunctive treatment in dogs with chronic enteropathy: a randomised controlled trial

Journal of Small Animal Practice, Volume 67, Issue 9, Page 798-809, September 2026.
Objectives To evaluate the clinical benefit of faecal microbiota transplantation administered via a single retention enema, as an adjunctive treatment in the management of dogs with chronic enteropathy. Materials and Methods Blinded, randomised controlled trial.
F. Allerton, M. J. Whittle, L. Durkin, C. Prior, M. Trehy, H. Swales, F. Duplan, S. Borgonovi, G. Pinchbeck, I. Gajanayake, M. Dunning, T. Sparks, P. Watson, G. C. A. Amos, K. McCallum, J. Bazelle, A. Kent   +16 more
wiley   +1 more source

Recurrence of Clostridioides difficile infection and mortality in older inpatients

Purpose The prevalence of Clostridioides difficile infection in older and frail population is extremely high and adverse outcomes, including future recurrences and premature mortality, are common. Nonetheless, the clinical risk profile for Clostridioides
Volpato, Stefano, Cultrera, Rosario, Govoni, Benedetta, Mattioli, Irene, Zurlo, Amedeo, De Giorgio, Roberto, Remelli, Francesca   +6 more
core   +1 more source

Механизмы антибактериальной резистентности Clostridium (clostridioides) difficile

Aim of the review. To study and consolidate recent data on Clostridium (Clostridioides) difficile antibacterial resistance mechanisms. Key points. There is objective data about the spread of antimicrobial resistant Clostridium (Clostridioides) difficile ...
Makesheva A.B., Kashnikov V.N., Sukhina M.A., Shelygin Y.A.   +3 more
core   +1 more source

In silico interaction of catalytic domain of Clostridioides difficile toxins TcdA and TcdB with some selected compounds from the SuperNatural 3.0 database

Kuwait Journal of Science
Clostridioides difficile is a pathogenic bacterium responsible for antibiotic-associated diarrhea globally. The pathogenesis of this bacterium is due to its virulence toxins, which inactivate the small GTPases from the Rho and Ras families in host cells,
doaj   +1 more source

Comparison of <i>Clostridioides difficile</i> Infection Incidence in Cirrhotic Patients Receiving Secondary Spontaneous Bacterial Peritonitis Prophylaxis With Ciprofloxacin vs. Trimethoprim-Sulfamethoxazole. [PDF]

Gastroenterology Res
Barbarovich A, Patel R, Singh H, Slaton J, Royall NA.   +4 more
europepmc   +1 more source

Fecal filtrate transplantation as salvage therapy for fulminant <i>Clostridioides difficile</i> infection in adult hematological patients during chemotherapy-induced aplasia: a pilot experience. [PDF]

Gut Microbes
Korózs D, Szabó BG, Apjok G, Lakatos V, Jeszenszky K, Kamotsay K, Hajbel-Vékony G, Tóth Á, Sinkó J, Reményi P, Kintses B.   +10 more
europepmc   +1 more source

Neutropenia and the Risk of Clostridioides difficile Infection, Fungemia, and Bacteremia: A Nationwide Inpatient Sample Analysis. [PDF]

Cureus
Suliman A, Teran L.
europepmc   +1 more source

Development of a checklist to support management of older patients with <i>Clostridioides difficile</i> infection. [PDF]

BMJ Open Qual
Rubak T, Dahl Baunwall SM, Paaske SE, Ørum M, Kongensgaard R, Kjærskov Hansen T, Gregersen M, Hvas CL.   +7 more
europepmc   +1 more source

Epidemiology of Clostridioides difficile infections

Ciljevi istraživanja: Ciljevi istraživanja su utvrditi učestalost infekcije C. difficile u KBC Osijek (2021 - 2024), analizirati rezultate testiranja, ispitati demografske karakteristike oboljelih te procijeniti povezanost demografskih faktora s ...
Šimović, Tihana
core   +1 more source

MANAGEMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF ANTIBIOTIC EFFICACY. [PDF]

Arq Gastroenterol
Pelucio IB, Malaguti C, Oliveira TMD, Chitarra KMSM, Furtado MCV, Chebli JMF.   +5 more
europepmc   +1 more source